SINGAPORE INST OF ADV MED LTD.
(SGX: 9G2)

Incorporated in 2011, Singapore Institute of Advanced Medicine Holdings Ltd. (the "Company" and together with its subsidiaries, the "Group") is a healthcare service provider using advanced technology for early and accurate diagnosis and offering appropriate treatments to achieve better outcomes and quality of life for its patients. The Group's services cater to a wide spectrum of diseases and health conditions including, but not limited to, cancer, neurodegenerative and cardiovascular disease detection, and treatment. The Group is primarily engaged in the following key business segments: (i) Medical Diagnostics and Treatments; and (ii) Radiation Therapy and Medical Oncology Services. The Company's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer. The Group aims to do this by bringing together a dedicated team of professionals and experts from the industry who will work with the Group to seek solutions for the diagnosis and treatment of cancer patients and improve their quality of life.

0.055 -

- (-%)
Range 0.055 - 0.055   (-%)
Open 0.055
Previous Close 0.055
Bid Price 0.051
Bid Volume ('000) 7
Ask Price 0.055
Ask Volume ('000) 10
Volume ('000) 100
Value 5,500
Remark -
Delayed prices. Updated at 20 Dec 2024 14:59.
Data powered by

Upcoming Events

AGM

Meeting Date 27 December 2024
Meeting Time 2:30 PM
2.30 P.M. AT 1 BIOPOLIS DRIVE, AMNIOS, SINGAPORE 138622, LEVEL 2, AUDITORIUM.
Data powered by SGX.
View All Events


Loading Chart...

Please login to view stock data and analysis